Inherited disorders of neonatal lung diseases

Turkish Journal of Pediatrics

Volumn 46, Issue 2, 2004, Pages 105-114

  Yurdakök, Murat ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Genetics; Inherited disorders; Respiratory distress; Surfactant proteins

Indexed keywords

COLLECTIN; MYELIN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; SURFACTANT PROTEIN D;

ALLELE; CLINICAL FEATURE; GENE IDENTIFICATION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK POPULATION; HOMOZYGOSITY; HUMAN; INFANT; LUNG ALVEOLUS CELL TYPE 2; LUNG DYSPLASIA; LUNG TRANSPLANTATION; MORBIDITY; MOUSE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NEWBORN MORTALITY; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PROTEIN DEFICIENCY; RESPIRATORY FAILURE; REVIEW; RISK FACTOR; SURFACE TENSION; VISCOELASTICITY;

HUMANS; INFANT, NEWBORN; MUTATION; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; PULMONARY SURFACTANT-ASSOCIATED PROTEIN C; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 2942541170     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Cole FS, Hamvas A, Nogee LM. Genetic disorders of neonatal respiratory function. Pediatr Res 2001; 50: 157-162.
2. Hallman M, Haataja R. Genetic influences and neonatal lung disease. Semin Neonatol 2003; 8: 19-27.
3. Hamvas A, Cole FS, Nogee LM. Inherited disorders of surfactant protein metabolism. Biol Neonate 2002; 82: 276-277.
4. Khoury MJ, Marks JS, McCarthy BJ, Zaro SM. Factors affecting the sex differential in neonatal mortality: the role of respiratory distress syndrome. Am J Obstet Gynecol 1985; 151: 777-782.
5. Hulsey TC, Alexander GR, Robillard PY, Annibale DJ, Keenan A. Hyaline membrane disease: the role of ethnicity and maternal risk characteristics. Am J Obstet Gynecol 1993; 168: 572-576.
6. Martilla R, Haataja R, Ramet M, et al. Evaluation of the genetic susceptibility to RDS in monozygotic and dizygotic twins. Pediatr Res 2001; 49: 387A.
7. Marttila R, Haataja R, Ramet M, Lofgren J, Hallman M. Surfactant protein B polymorphism and respiratory distress syndrome in premature twins. Hum Genet 2003; 112: 18-23.
8. Hamvas A, Wise PH, Yang RK, et al. The influence of the wider use of surfactant therapy on neonatal mortality among blacks and whites. N Engl J Med 1996; 334: 1635-1640.
9. Khoury MJ, Calle EE, Joesoef RM. Recurrence of low birth weight in siblings. J Clin Epidemiol 1989; 42: 1171-1178.
10. Raven SN, Misenheimer HR. Respiratory distress syndrome and the high risk mother. Am J Dis Child 1965; 109: 489-494.
11. Lankenau HM. A genetic and statistical study of the respiratory distress syndrome. Eur J Pediatr 1976; 123: 167-177.
12. Nagourney BA, Kramer MS, Klebanoff MA, Usher RH. Recurrent respiratory distress syndrome in successive preterm pregnancies. J Pediatr 1996; 129: 591-596.
13. McColley SA. Bronchopulmonary dysplasia: impact of surfactant replacement therapy. Pediatr Clin North Am 1998; 45: 573-586.
14. Parker RA, Lindstrom DP, Cotton RB. Evidence from twin study implies possible genetic susceptibility to bronchopulmonary dysplasia. Semin Perinatol 1996; 20: 206-209.
15. Mallory GB Jr. Surfactant proteins: role in lung physiology and disease in early life. Paediatr Resp Rev 2001; 2: 151-158.
16. Korfhagen TR, Bruno MD, Ross GF, et al. Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci USA 1996; 93: 9594-9599.
17. Ikegami M, Korfhagen TR, Whitsett JA, et al. Characteristics of surfactant from SP-A-deficient mice. Am J Physiol 1998;. 275: L247-L254.
18. Ikegami Mm, Korfhagen TR, Bruno MD, Whitsett JA, Jobe AH. Surfactant metabolism in surfactant protein A-deficient mice. Am J Physiol 1997; 272: L479-L485.
19. Levine AM, Kurak KE, Bruno MD, Stark JM, Whitsett JA, Korfhagen TR. Surfactant protein-A deficient mice are susceptible to Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol 1998; 19: 700-708.
20. Levine AM, Gwozdz J, Stark J, Bruno M, Whitsett J, Korfhagen T. Surfactant protein-A enhances respiratory syncytial virus clearance in vivo. J Clin Invest 1999; 103: 1015-1021.
21. Meyer KC, Zimmerman J. Inflammation and surfactant. Paediatr Resp Rev 2002; 3: 308-314.
22. Wright JR. Pulmonary surfactant: a front line of lung host defense. J Clin Invest 2003; 111: 1453-1455.
23. McCormack FX, Whitsett JA. The pulmonary collections, SP-A and SP-D, orchestrate innate immunity in the lung. J Clin Invest 2002; 109: 707-712.
24. Pantelidis P, Veeraraghavan S, du Bois RM. Surfactant gene polymorphisms and interstitial lung diseases. Respir Res 2002; 3: 14-21.
25. Floros J, Hoover RR. Genetics of the hydrophilic surfactant proteins A and D. Biochim Biophys Acta 1998; 1408: 312-322.
26. Hamvas A. Surfactant protein B deficiency: insights into inherited disorders of lung cell metabolism. Curr Probl Pediatr 1997; 27: 325-345.
27. Haataja R, Ramet M, Martilla R, Hallman M. Surfactant proteins A and B as interactive genetic determinants of neonatal respiratory distress syndrome. Hum Mol Genet 2000; 9: 2751-2760.
28. Kala P, Ten Have T, Nielsen H, Dunn M, Floros J. Association of pulmonary surfactant protein A (SP-A) gene and respiratory distress syndrome. Interaction with SP-B. Pediatr Res 1998; 43: 169-177.
29. Ramet M, Haataja R, Martilla R, Floros J, Hallman M. Association between the surfactant protein A (SP-A) gene locus and respiratory-distress syndrome in the Finnish population. Am J Hum Genet 2000; 66: 1569-1579.
30. Haataja R, Martilla R, Uimari P, Logren J, Ramet M. Respiratory distress syndrome: evaluation of genetic susceptibility and protection by transmission disequilibrium test. Hum Genet 2001; 109: 351-355.
31. Karinch AM, deMello DE, Foloros J. Effect of genotype on the levels of surfactant protein A mRNA and on the SP-A2 splice variants in adults humans. Biochem J 1997; 321: 39-47.
32. Floros J, Kala P. Surfactant proteins: molecular genetics of neonatal plumonary diseases. Annu Rev Physiol 1998; 60: 365-384.
33. Hawgood S, Derrick M, Poulain F. Structure and properties of surfactant protein B. Biochim Biophys Acta 1998; 1408: 150-160.
34. Clark JC, Wert SE, Bachurski CJ, et al. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newbron mice. Proc Natl Acad Sci USA 1995; 92: 7794-7798.
35. Whitsett JA, Weaver TE. Hydrophobic surfactant proteins in lung function and disease. N Engl J Med 2002; 347: 2141-2148.
36. Nogee LM, Wert SE, Proffit SA, Hull WM, Whitsett JA. Allelic heterogeneity in hereditary surfactant protein B (SP-B) deficiency. Am J Respir Crit Care Med 2000; 161: 973-981.
37. Hamvas A, Cole FS, deMello DE, et al. Surfactant protein B deficiency: antenatal diagnosis and prospective treatment with surfactant replacement. J Pediatr 1994; 125: 356-361.
38. Nogee LM, de Mello DE, Dehner LP, Colten HR. Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med 1993; 328: 406-410.
39. Cole FS, Hamvas A, Rubinstein P, et al. Population-based estimates of surfactant protein B deficiency. Pediatrics 2000; 105: 538-541.
40. Nogee LM, Wertt SE, Proffit SA, Hull WM, Whitsett JA. Allelic heterogeneity in hereditary surfactant protein B (SP-B) deficiency. Am J Respir Crit Care Med 2000; 161: 973-981.
41. Nogee LM. Surfactant protein-B deficiency. Chest 1997; 111 (Suppl): 129S-135S.
42. Nogee LM, Garnier G, Dietz HC, et al. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest 1994; 93: 1860-1863.
43. Hamvas A, Nogee LM, Mallory GB Jr, et al. Lung transplantation for treatment of infants with surfactant protein B deficiency. J Pediatr 1997; 130: 231-239.
44. Beers MF, Hamvas A, Moxley MA, et al. Pulmonary surfactant metabolism in infants lacking surfactant protein B. Am J Respir Cell Mol Biol 2000; 22: 380-391.
45. Vorbroker DK, Profitt SA, Nogee LM, Whitsett JA. Aberrant processing of surfactant protein C in hereditary SP-B deficiency. Am J Physiol 1995; 268: L647-L656.
46. Stuhrmann M, Bohnhorst B, Peters U, Bohle RM, Poets CF, Schmidtke J. Prenatal diagnosis of congenital alveolar proteinosis (surfactant protein B deficiency). Prenat Diagn 1998; 18: 953-955.
47. Klein JM, Thompson MW, Snyder JM, et al. Transient surfactant protein B deficiency in a term infant with severe respiratory failure. J Pediatr 1998; 132: 244-248.
48. Yusen RD, Cohen AH, Hamvas A. Normal lung function in subjects heterozygous for surfactant protein-B deficiency Am J Respir Crit Care Med 1999; 159: 411-414.
49. Ballard PL, Nogee LM, Beers MF, et al. Partial deficiency of surfactant protein B in an infant with chronic lung disease. Pediatrics 1995; 96: 1046-1052.
50. Akinbi HT, Breslin JS, Ikegami M, et al. Rescue of SP-B knockout mice with a truncated SP-B proprotein: function of the C-terminal propeptide. J Biol Chem 1997; 272: 9640-9647.
51. Tokieda K, Ikegami M, Wert SE, Baatz JE, Zou Y, Whitsett JA. Surfactant protein B corrects oxygen-induced pulmonary dysfunction in heterozygous surfactant protein B-deficient mice. Pediatr Res 1999; 46: 708-714.
52. Dunbar AE III, Wert SE, Ikegami M, et al. Prolonged survival in hereditary surfactant protein B (SP-B) deficiency associated with a novel splicing mutation. Pediatr Res 2000; 48: 275-282.
53. Mildenberger E, de Mello DE, Lin Z, Kössel H, Hoehn T, Versmold HT. Focal congenital alveolar proteinosis associated with abnormal surfactant protein B messenger RNA. Chest 2001; 119: 645-647.
54. Marttila R, Haataja R, Ramet M. Löfgren J, Hallman M. Surfactant protein B polymorphism and respiratory distress syndrome in premature twins. Hum Genet 2003; 112: 18-23.
55. Lin Z, deMello DE, Batanian JR, et al. Aberrant SP-B mRNA in lung tissue of patients with congenital alveolar proteinosis (CAP). Clin Genet 2000; 57: 359-369. [Erratum in: Clin Genet 2000; 58: 156].
56. Johansson J. Structure and properties of surfactant protein C. Biochim Biophys Acta 1998; 1408: 161-172.
57. Glasser WS, Burhans MS, Korfhagen TR, et al. Generation of an SP-C deficient mouse by targeted gene inactivation (Abstract). Am J Respir Crit Care Med 2000, 161: A43.
58. Nogee LM, Dunbar AE, Wertü SE, Askin F, Hamvas A, Whitsett JA. A mutation in the surfactant protein C (SP-C) gene associated with familial interstitial lung disease. N Engl J Med 2001; 344: 573-579.
59. Nogee LM, Dunbar AE III, Wert S, Askin F, Hamvas A, Whitsett JA. Mutations in the surfactant protein C gene associated with interstitial lung disease. Chest 2002; 121 (Suppl): 20S-21S.
60. Thomas AQ, Lane K, Philips J 3rd, et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med 2002; 165: 1322-1328.
61. Lahti M, Logren J, Marttila P. et al. Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection. Pediatr Res 2002; 51: 696-699.
62. Wert SE, Yoshida M, LeVine AM, et al. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc Natl Acad Sci USA 2000; 97: 5972-5977.
63. Botas C, Poulain R, Akiyama J, et al. Altered surfactant homeostasis and alveolar type II cell morphology inmice lacking surfactant protein D. Proc Natl Acad Sci USA 1998; 95: 11869-11874.
64. Cutz E, Wert SE, Nogee LM, Moore AM. Deficiency of lamellar bodies in alveolar type II cells associated with fatal respiratory disease in a full-term infant. Am J Respir Crit Care Med 2000; 161: 608-614.
65. Pitkanen O. Lung epithelial ion transport in neonatal lung disease. Biol Neonate 2001; 80 (Suppl): 14-17.
66. Compernolle V, Brusselmans K, Acker T, et al. Loss of HIF-2alpha and inhibition of VEGF prevents fatal respiratory distress in premature mice. Nat Med 2002; 8: 702-710.
67. Waterer GW, Quasney MW, Cantor RM, Wunderink RG. Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations. Am J Respir Crit Care Med 2001; 163: 1599-1604.
68. Dranoff G, Crawford AD, Sadelain M, et al. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 1994; 264: 713-716.
69. Dirksen U, Nishinakamura R, Groneck P et al. Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression. J Clin Invest 1997; 100: 2211-2217.
70. Kitamura T, Tanaka N, Watanabe J, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med 1999; 190: 875-880.
71. Thomassen MJ, Yi T, Raychaudhuri B, Malur A, Kavuru MS. Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect. Cell Immunol 2000, 95: 85-92.
72. Vayrynenn O, Glumoff V, Hallman M. Regulation of surfactant proteins by LPS and proinflammatory cytokines in fetal and newborn lung. Am J Physiol Lung Cell Mol Physiol 2002; 282: L803-L810.
73. Hoover RR, Floros J. SP-A 3′UTR is involved in the glucocorticoid inhibition of human SP-A gene expression. Am J Physiol 1999; 276: L917-L924.